Key facts
- Sobi will present new data on pegcetacoplan at the 63rd ERA Congress.
- The data pertains to research in C3 glomerulopathy (C3G) and primary immune-complex membranoproliferative glomerulonephritis (IC-MPGN).
The ERA Congress (European Renal Association) is a key event for nephrology professionals, showcasing the latest advancements in kidney disease treatment and research. Sobi's presentation of data on pegcetacoplan highlights ongoing research and development in treating specific kidney diseases.